한국어
English
日本語
中文(简体)Femazair Tablets 13.5 mg (Femicatinib)
13.5mg
Tablet · Prescription medication
Handok Co., Ltd.
Pemigatinib is an antitumor ingredient used for the treatment of certain cancers by inhibiting FGFR.
MFDS ingredient code M283698
Pemigatinib is a targeted cancer therapy that targets FGFR (fibroblast growth factor receptor) and is used to inhibit the growth and proliferation of cancer cells. This ingredient is applied to cancer patients with specific genetic mutations to enhance therapeutic effects.
Pemigatinib blocks FGFR signaling on the surface of cancer cells, preventing abnormal cell proliferation. This leads to the inhibition of cancer cell growth and spread, resulting in therapeutic effects.
Approved uses differ by product. Check each product's information for its actual use.
Pemigatinib is a targeted therapy that selectively inhibits FGFR, characterized by acting on specific molecular targets, unlike conventional chemotherapy, thus reducing side effects and enhancing therapeutic efficacy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.